{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:47:05Z","timestamp":1754160425630,"version":"3.41.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,26]]},"DOI":"10.7759\/cureus.88821","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T20:03:59Z","timestamp":1753560239000},"source":"Crossref","is-referenced-by-count":0,"title":["Conduit Bleeding Unmasks Isolated Distal Ureter Recurrence After Radical Cystectomy: Lessons in Laparoscopic Nephroureterectomy and Surveillance"],"prefix":"10.7759","author":[{"given":"Roshan","family":"Yedulla Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajan","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubina","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandru","family":"T","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natarajan","family":"Kumaresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.05.031","article-title":"The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review","volume":"66","author":"Bruins HM","year":"2014","unstructured":"Bruins HM, Veskimae E, Hernandez V, et al.. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. Eur Urol. 2014, 66:1065-77. 10.1016\/j.eururo.2014.05.031","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.03.002","article-title":"Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy","volume":"39","author":"Aumatell J","year":"2021","unstructured":"Aumatell J, Huguet J, Subiela JD, et al.. Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy. Urol Oncol. 2021, 39:732.e1-8. 10.1016\/j.urolonc.2021.03.002","journal-title":"Urol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.336","article-title":"Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy","volume":"5","author":"Yamashita R","year":"2024","unstructured":"Yamashita R, Nakamura M, Notsu A, et al.. Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy. BJUI Compass. 2024, 5:483-9. 10.1002\/bco2.336","journal-title":"BJUI Compass"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2022.07.003","article-title":"Urothelial carcinoma: divergent differentiation and morphologic subtypes","volume":"15","author":"Gandhi J","year":"2022","unstructured":"Gandhi J, Chen JF, Al-Ahmadie H. Urothelial carcinoma: divergent differentiation and morphologic subtypes. Surg Pathol Clin. 2022, 15:641-59. 10.1016\/j.path.2022.07.003","journal-title":"Surg Pathol Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet F","year":"2019","unstructured":"Audenet F, Isharwal S, Cha EK, et al.. Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma. Clin Cancer Res. 2019, 25:967-76. 10.1158\/1078-0432.CCR-18-2039","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang SS","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, et al.. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J Urol. 2016, 196:1021-9. 10.1016\/j.juro.2016.06.049","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0148-8","article-title":"Understanding, justifying, and optimizing radiation exposure for CT imaging in nephrourology","volume":"16","author":"Ferrero A","year":"2019","unstructured":"Ferrero A, Takahashi N, Vrtiska TJ, Krambeck AE, Lieske JC, McCollough CH. Understanding, justifying, and optimizing radiation exposure for CT imaging in nephrourology. Nat Rev Urol. 2019, 16:231-44. 10.1038\/s41585-019-0148-8","journal-title":"Nat Rev Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-013-0955-6","article-title":"Magnetic resonance urography vs computed tomography urography in the evaluation of patients with haematuria","volume":"118","author":"Martingano P","year":"2013","unstructured":"Martingano P, Cavallaro MF, Bertolotto M, Stacul F, Ukmar M, Cova MA. Magnetic resonance urography vs computed tomography urography in the evaluation of patients with haematuria. Radiol Med. 2013, 118:1184-98. 10.1007\/s11547-013-0955-6","journal-title":"Radiol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19043","article-title":"Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer","volume":"8","author":"Kusaka A","year":"2017","unstructured":"Kusaka A, Hatakeyama S, Hosogoe S, et al.. Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer. Oncotarget. 2017, 8:65492-505. 10.18632\/oncotarget.19043","journal-title":"Oncotarget"},{"key":"ref10","unstructured":"Tests and procedures. Accessed. July 26, 2025: https:\/\/www.mayoclinic.org\/tests-procedures."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5321613","article-title":"Robot-assisted nephroureterectomy for upper tract urothelial carcinoma in a patient with an ileal conduit","volume":"2022","author":"Stemrich RA","year":"2022","unstructured":"Stemrich RA, Patel NH, Baber JA, Ferretti MJ. Robot-assisted nephroureterectomy for upper tract urothelial carcinoma in a patient with an ileal conduit. Case Rep Urol. 2022, 2022:5321613. 10.1155\/2022\/5321613","journal-title":"Case Rep Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3316-7","article-title":"The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy","volume":"80","author":"Sun P","year":"2017","unstructured":"Sun P, Xue C, Li LR, et al.. The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy. Cancer Chemother Pharmacol. 2017, 80:37-44. 10.1007\/s00280-017-3316-7","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00472","article-title":"Clinical utility of serial circulating tumor DNA analysis as a minimally invasive biomarker in advanced urothelial cancer","volume":"9","author":"Sakatani T","year":"2025","unstructured":"Sakatani T, Sumiyoshi T, Kita Y, et al.. Clinical utility of serial circulating tumor DNA analysis as a minimally invasive biomarker in advanced urothelial cancer. JCO Precis Oncol. 2025, 9:e2400472. 10.1200\/PO-24-00472","journal-title":"JCO Precis Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle A","year":"2020","unstructured":"Birtle A, Johnson M, Chester J, et al.. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020, 395:1268-77. 10.1016\/S0140-6736(20)30415-3","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32806","article-title":"Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and\/or cell-free DNA results","volume":"126","author":"Pal SK","year":"2020","unstructured":"Pal SK, Bajorin D, Dizman N, et al.. Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and\/or cell-free DNA results. Cancer. 2020, 126:2597-606. 10.1002\/cncr.32806","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-021-02413-4","article-title":"Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture","volume":"407","author":"Krafft U","year":"2022","unstructured":"Krafft U, Mahmoud O, Hess J, et al.. Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture. Langenbecks Arch Surg. 2022, 407:1233-40. 10.1007\/s00423-021-02413-4","journal-title":"Langenbecks Arch Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.02.006","article-title":"25 years of experience with 1,000 neobladders: long-term complications","volume":"185","author":"Hautmann RE","year":"2011","unstructured":"Hautmann RE, de Petriconi RC, Volkmer BG. 25 years of experience with 1,000 neobladders: long-term complications. J Urol. 2011, 185:2207-12. 10.1016\/j.juro.2011.02.006","journal-title":"J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: A 2020 systematic review and meta-analysis, and future perspectives on systemic therapy","volume":"79","author":"Leow JJ","year":"2021","unstructured":"Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J. Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: A 2020 systematic review and meta-analysis, and future perspectives on systemic therapy. Eur Urol. 2021, 79:635-54. 10.1016\/j.eururo.2020.07.003","journal-title":"Eur Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14710-x","article-title":"Upper urinary tract urothelial cancer after radical cystectomy for bladder cancer: survival outcomes after radical nephroureterectomy","volume":"31","author":"\u015alusarczyk A","year":"2024","unstructured":"\u015alusarczyk A, Zapa\u0142a P, Piecha T, Zapa\u0142a \u0141, Borkowski T, Radziszewski P. Upper urinary tract urothelial cancer after radical cystectomy for bladder cancer: survival outcomes after radical nephroureterectomy. Ann Surg Oncol. 2024, 31:2144-53. 10.1245\/s10434-023-14710-x","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385573-conduit-bleeding-unmasks-isolated-distal-ureter-recurrence-after-radical-cystectomy-lessons-in-laparoscopic-nephroureterectomy-and-surveillance","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T20:04:00Z","timestamp":1753560240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385573-conduit-bleeding-unmasks-isolated-distal-ureter-recurrence-after-radical-cystectomy-lessons-in-laparoscopic-nephroureterectomy-and-surveillance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.88821","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,26]]}}}